We assist you in:
Early market access assessment
We will help you in ensuring that your innovation will be fit for your target healthcare market at an early stage of development. Our services include early market access landscape assessment, early product value assessment, early payer engagement and communication with payer advisory boards, value dossier development, and the development of payer communication tools.
National market access strategy
Assessing the added value of your new product or service is crucial to demonstrate this value to potential investors and decision-makers. We offer a range of services to help you achieve national market access, which include Health Technology Assessment (HTA) and reimbursement submissions, systematic and rapid literature reviews, cost-consequence and cost-effectiveness modeling, budget impact modeling, and publications in high-impact journals. We want to ensure that your product or service will achieve recommendations and endorsements from key healthcare actors and decision-makers in your country of interest.
Global market access strategy
Launching a new product or service on a global scale comes with its own set of regulatory challenges. Our team will support you in the development of global value dossiers, core health economic models, and conducting country-specific adaptations of health economic models.
